89 related articles for article (PubMed ID: 27272829)
1. Potential Impact of the Overall Treatment Time on Outcomes after Whole-brain Irradiation with 10×3 Gy for Brain Metastases.
Rades D; Janssen S; Veninga T; Schild SE
Anticancer Res; 2016 Jun; 36(6):3071-4. PubMed ID: 27272829
[TBL] [Abstract][Full Text] [Related]
2. Outcomes After Whole-brain Radiotherapy for Brain Metastases with 5×4 Gy: Importance of Overall Treatment Time.
Rades D; Veninga T; Janssen S; Schild SE
Anticancer Res; 2016 Sep; 36(9):4941-5. PubMed ID: 27630352
[TBL] [Abstract][Full Text] [Related]
3. Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.
Rades D; Kueter JD; Meyners T; Pluemer A; Veninga T; Gliemroth J; Schild SE
Clin Neurol Neurosurg; 2012 May; 114(4):326-30. PubMed ID: 22152784
[TBL] [Abstract][Full Text] [Related]
4. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
5. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017
[TBL] [Abstract][Full Text] [Related]
6. Clinical Factors Asssociated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer.
Dziggel L; Schild SE; Veninga T; Bajrovic A; Rades D
In Vivo; 2017 Jan; 31(1):35-38. PubMed ID: 28064217
[TBL] [Abstract][Full Text] [Related]
7. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
[TBL] [Abstract][Full Text] [Related]
9. Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
Dziggel L; Gebauer N; Bartscht T; Schild SE; Rades D
Anticancer Res; 2018 Apr; 38(4):2391-2394. PubMed ID: 29599366
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.
Meyners T; Heisterkamp C; Kueter JD; Veninga T; Stalpers LJ; Schild SE; Rades D
BMC Cancer; 2010 Oct; 10():582. PubMed ID: 20977700
[TBL] [Abstract][Full Text] [Related]
12. A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.
Rades D; Janssen S; Dziggel L; Blanck O; Bajrovic A; Veninga T; Schild SE
BMC Cancer; 2017 Jan; 17(1):30. PubMed ID: 28061768
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
Rades D; Haatanen T; Schild SE; Dunst J
Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
[TBL] [Abstract][Full Text] [Related]
14. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
15. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
16. Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection.
Rades D; Veninga T; Hornung D; Wittkugel O; Schild SE; Gliemroth J
Cancer; 2012 Feb; 118(4):1138-44. PubMed ID: 21761403
[TBL] [Abstract][Full Text] [Related]
17. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
18. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
19. Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis.
Buecker R; Hong ZY; Liu XM; Jaenke G; Lu P; Schaefer U
Radiat Oncol; 2019 Mar; 14(1):41. PubMed ID: 30866972
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
Rades D; Fischer D; Veninga T; Stalpers LJ; Schild SE
Gynecol Oncol; 2009 Sep; 114(3):506-8. PubMed ID: 19540574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
